| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 07/19/2007 | US20070166330 gM-NEGATIVE EHV-MUTANTS WITHOUT HETEROLOGOUS ELEMENTS |
| 07/19/2007 | US20070166328 Genetic immunization against cervical carcinoma |
| 07/19/2007 | US20070166326 immunogenically active component of West Nile virus or plasmid DNA which is pCBWN, an adjuvant such as a metabolizable oil, and a pharmacologically acceptable carrier are formulated into an immunizing vaccine for preventing West Nile disease, such as encephalitis in equine |
| 07/19/2007 | US20070166325 immunogenically active component of West Nile virus or plasmid DNA which is pCBWN, an adjuvant such as a metabolizable oil, and a pharmacologically acceptable carrier are formulated into an immunizing vaccine for preventing West Nile disease, such as encephalitis in equine |
| 07/19/2007 | US20070166324 West Nile vaccine |
| 07/19/2007 | US20070166322 Adjuvant viral particle |
| 07/19/2007 | US20070166287 Oncolytic virus |
| 07/19/2007 | US20070166284 Therapeutic regimen for treating cancer |
| 07/19/2007 | DE19903056B4 HPV-Assay HPV Assay |
| 07/19/2007 | CA2636843A1 Method for determining the concentration of virus particles/virus antigens |
| 07/18/2007 | EP1808697A1 Use of an ion exchange matrix for determining the concentration of virus particles and/or virus antigens |
| 07/18/2007 | EP1808180A2 Modified GP 100 and uses thereof |
| 07/18/2007 | EP1807511A2 Stable and filterable enveloped virus formulations |
| 07/18/2007 | EP1186667B1 Envelope gene-deficient virus vector of paramyxoviridae |
| 07/18/2007 | EP1088077B1 Newcastle disease virus infectious clones, vaccines and diagnostic assays |
| 07/18/2007 | EP0981537B1 An infectious clone for human parainfluenza virus type 3 |
| 07/18/2007 | CN1327000C Shuttle vector of repeatable adenovirus of targeting melanoma and adenovirus |
| 07/18/2007 | CN1326992C Composition and method for increasing cell density in cell cultures infected with lentivirus |
| 07/18/2007 | CN100999729A Expression of cattle gamma interferon in recombined rhabdovirus and testing of antivirus activity |
| 07/17/2007 | US7244820 Comprises insecticidal protein against lepidopteran insect pests; biological pest control and tissue engineering |
| 07/17/2007 | US7244715 Vaccines containing ribavirin and methods of use thereof |
| 07/17/2007 | US7244617 Generating transgenic cell comprising expression vector coding apotosis inducing factor for use in treatment of cell proliferative and viral disorders |
| 07/17/2007 | US7244585 Producing a recombinant or chimeric GBV-B virus by introducing into a host cell a genome composed of a 3' terminal sequence of GBV-B and culturing the host cell to produce the virus from the genome. |
| 07/17/2007 | US7244558 Production of novel Newcastle disease virus strains from cDNAs and improved live attenuated Newcastle disease vaccines |
| 07/17/2007 | US7244434 Expresses all structural proteins of a pestivirus (e.g., BVDV) except for a functional C protein; coding sequences for a signal sequence within the C protein essential for post translational processing are retained or replaced by a sequence for analogous signal sequences from another pestiviral species |
| 07/17/2007 | US7244432 A VP2 protein isolated from a variant Georgia strain of IBDV for use in reducing or preventing infection in poultry |
| 07/17/2007 | US7244422 Enhancing the effect of hepatitis vaccines, particularly hepatitus B vaccines, by the use of ribavirin as an adjuvant; single administration |
| 07/17/2007 | CA2145535C Adenovirus vectors for the transfer of foreign genes into cells of the central nervous system, particularly in brain |
| 07/12/2007 | WO2007077464A2 Chicken virus vaccine and diagnostic |
| 07/12/2007 | WO2007044483A3 Attenuated vaccines for non-segmented negative sense rna viruses |
| 07/12/2007 | US20070162993 Geranylgeranyl pyrophosphate synthases |
| 07/12/2007 | US20070161110 Methods for producing minus-strand rna viral vectors using hybrid promoter comprising cytomegalovirus enhancer and chicken beta-actin promoter |
| 07/12/2007 | US20070160629 Purified active HCV NS2/3 protease |
| 07/12/2007 | US20070160627 wherein IL1 beta R coding sequence has been inactivated for use in immunotherapy and vaccination, wherein MVA mutant comprises DNA sequences coding for a heterologous protein derived from therapeutic polypeptides and polypeptides of pathogenic agents, wherein MVA mutant leads to enhanced memory response |
| 07/12/2007 | CA2635560A1 Chicken virus vaccine and diagnostic |
| 07/11/2007 | EP1805298A1 Animal protein-free media for cultivation of cells |
| 07/11/2007 | EP1420822B1 Modified vaccinia virus ankara for the vaccination of neonates |
| 07/11/2007 | EP1370666B1 Genetic immunisation against cervical carcinoma |
| 07/11/2007 | EP1237925B1 Mutant er-alpha and test systems for transactivation |
| 07/11/2007 | EP1175486B1 Method for the preservation of viruses and mycoplasma |
| 07/11/2007 | EP1129100B1 Selection system for generating efficient packaging cells for lentiviral vectors |
| 07/11/2007 | EP1037917B1 Recombinant nodavirus compositions and methods |
| 07/11/2007 | CN1997746A Chimeric adenoviruses for use in cancer treatment |
| 07/11/2007 | CN1997734A Signal for packaging of influenza virus vectors |
| 07/11/2007 | CN1325653C Retroviral delivery system |
| 07/11/2007 | CN1325647C Selectively replicating viral vectors |
| 07/10/2007 | US7241591 Adenovirus comprising a gene coding for glutathione peroxidase |
| 07/10/2007 | US7241440 Identifying a subject in need of an increase in titer of IgG antibodies that are specific for a viral antigen; providing an immunogenic composition comprising ribavirin and a nucleic acid molecule encoding viral antigen. |
| 07/10/2007 | CA2366072C Prrsv vaccines |
| 07/10/2007 | CA2162149C Antibodies to p-selectin and their uses |
| 07/10/2007 | CA2007248C Meningococcal class 1 outer-membrane protein vaccine |
| 07/05/2007 | WO2007075179A2 Bacteriophage-quantum dot (phage-qd) nanocomplex to detect biological targets in clinical and environmental isolates |
| 07/05/2007 | WO2006052302A3 Method of producing and purifying adenoviral vectors |
| 07/05/2007 | US20070155008 use of low-medium perfusion rates in an attached cell culture system to provide for improved yields; improved Ad-p53 production with cells grown in serum-free conditions; offers scalability, validatability and virus purity comparable to that achieved using CsCl gradient ultracentrifugation |
| 07/05/2007 | US20070154902 Papilloma virus vaccine |
| 07/05/2007 | US20070154880 Process for the preparation and purification of recombinant proteins |
| 07/05/2007 | CA2673593A1 Immunologically enhanced recombinant vaccines |
| 07/04/2007 | EP1802746A2 Virosome particles comprising antigens from influenza virus and hepatitis b virus |
| 07/04/2007 | CN1993462A Adenoviral vector compositions |
| 07/04/2007 | CN1990859A Method of nucleus receptor ligand binding domain protein fusion expression on bacteriophage surface |
| 07/04/2007 | CN1990502A Coronal virus genetic engineering protein and use thereof |
| 07/03/2007 | US7238674 In situ injection; transduction; sustained release |
| 07/03/2007 | US7238526 Methods and cell line useful for production of recombinant adeno-associated viruses |
| 07/03/2007 | US7238481 administering HETEROLOGOUS GENE PRODUCTS IN HOST CELL SYSTEMS AND/OR TO RESCUE NEGATIVE STRAND RNA RECOMBINANT VIRUSES |
| 07/03/2007 | US7238478 Compositions and methods for protein isolation |
| 07/03/2007 | US7238356 Core-glycosylated HCV envelope proteins |
| 07/03/2007 | US7238349 Composition |
| 07/03/2007 | CA2359177C Bhv-1 gene-deleted virus vaccine |
| 07/03/2007 | CA2158869C Recombinant virus, process for preparing the same and use thereof in gene therapy |
| 06/28/2007 | WO2007072049A2 Particle binding |
| 06/28/2007 | WO2006076003A3 Vaccinia virus strains |
| 06/28/2007 | US20070148774 Methods for producing members of specific binding pairs |
| 06/28/2007 | US20070148765 Preservative-containing virus formulations |
| 06/28/2007 | US20070148753 Preparation of cells for production of biologicals |
| 06/28/2007 | US20070148629 Composition for the preservation of viruses |
| 06/27/2007 | EP1801209A1 Modified human hepatitis c virus genomic rna having autonomous replicative competence |
| 06/27/2007 | EP1801204A1 Recombinant herpesvirus of turkeys and uses thereof |
| 06/27/2007 | EP1801201A1 Preparation of cells for production of biologicals |
| 06/27/2007 | EP1799837A1 Bacteriophages displaying functional enzymes and uses thereof |
| 06/27/2007 | EP1799814A1 Variants of hepatitis b virus with resistance to anti-viral nucleoside agents and applications thereof |
| 06/27/2007 | EP1799251A2 Chimeric phage-derived particles, methods for their production and use |
| 06/27/2007 | CN1989250A Tc-83-derived alphavirus vectors, particles and methods |
| 06/27/2007 | CN1989240A Vaccine comprising an attenuated pestivirus |
| 06/26/2007 | US7235394 Relates to determination of functional HCV virus genomic RNA sequences, construction of infectious HCV DNA clones, and to use of the clones or their derivatives in therapeutic, vaccine, and diagnostic applications |
| 06/26/2007 | US7235393 Method for direct rescue and amplification of integrated viruses from cellular DNA of tissues |
| 06/26/2007 | US7235392 Transforming B lymphocytes with Epstein-Barr virus, incubating transformed B lymphocytes with flavin N-oxide photosensitizer, adding non-toxic antioxidant, and exposing lymphocytes to activator such as photoradiation to activate photosensitizer |
| 06/26/2007 | US7235362 Compositions and methods for protein isolation |
| 06/26/2007 | US7235245 Chimeric lyssavirus nucleic acids and polypeptides |
| 06/26/2007 | US7235235 Alphavirus RNA replicon systems |
| 06/26/2007 | CA2295316C Homogeneous human papilloma virus capsomere containing compositions, methods for manufacture, and the use thereof as diagnostic, prophylactic or therapy |
| 06/26/2007 | CA2216827C Synthetic hpv6/11 hybrid l1 dna encoding human papillomavirus type 11 l1 protein |
| 06/26/2007 | CA2176215C Stable cell lines capable of expressing the adeno-associated virus replication gene |
| 06/21/2007 | WO2006113435A3 Method for porcine circovirus production and assays for monitoring production |
| 06/21/2007 | US20070143877 Plant virus vector |
| 06/21/2007 | US20070142625 Virus filtration of liquid Factor VII compositions |
| 06/21/2007 | US20070141705 Method for producing viral vectors |
| 06/21/2007 | US20070141699 Methods of using the signal to transmit and maintain influenza viral and foreign nucleic acid in virus and cells; hemagglutinin (HA) and neuraminidase (NA). |
| 06/21/2007 | US20070141617 Enveloped virus vaccine and method for production |
| 06/21/2007 | US20070141561 Microfluidic device and method for concentration or purification of sample containing cells or viruses |
| 06/21/2007 | US20070141078 Monovalent; low dose of egg-derived influenza virus antigen from an influenza virus strain associated with or having the potential to cause a pandemic outbreak (e.g. H5N1antigen), with an oil in water emulsion adjuvant of an oil, alpha-tocopherol, and an emulsifier; can be made quickly in pandemic |